Ben-Tzvi Avraham
SEC insider (Form 3/4/5 filer). CIK 0001944721. Director at Quantum Cyber N.V. (QUCY) and 7 other issuers. 8 reported Form 4/5 transactions since Sep 2024; latest on Jul 31, 2026. Located in NORWALK, CT.
Companies Ben-Tzvi Avraham has filed insider reports for
- Quantum Cyber N.V. (QUCY): Director
- Aterian, Inc. (ATER): Director
- Black Titan Corp (BTTC): Director
- Indaptus Therapeutics, Inc. (INDP): Director
- TITAN PHARMACEUTICALS INC (TTNP): Director
- Cyclacel Pharmaceuticals, Inc. (CYCC): Director
- LQR House Inc. (LQR): Director
- MINIM, INC. (MINM): Director
Ben-Tzvi Avraham
CIK: 0001944721
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jul 31, 2026QUCY
Quantum Cyber N.V.
AwardDirect112.3K shares- - Jul 22, 2026QUCY
Quantum Cyber N.V.
AwardDirect112.9K shares- - May 8, 2026MYNZ
Quantum Cyber N.V.
AwardDirect137.1K shares- - Jan 20, 2026INDP
Indaptus Therapeutics, Inc.
AwardDirect25K shares- - Dec 23, 2025INDP
Indaptus Therapeutics, Inc.
AwardDirectOption to Buy Common Stock
25K shares- - Oct 1, 2025TTNP
TITAN PHARMACEUTICALS INC
DispositionDirect3.3K shares- - Feb 26, 2025CYCC
Cyclacel Pharmaceuticals, Inc.
AwardDirectNon-Qualified Stock Option (Right to Buy)
700K shares- - Sep 26, 2024MINM
MINIM, INC.
AwardIndirect159.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 31, 2026 |  QUCY Quantum Cyber N.V. | Award | 112,259 | - | $0 | Direct |
| Jul 22, 2026 | QUCY Quantum Cyber N.V. | Award | 112,859 | - | $0 | Direct |
| May 8, 2026 |  MYNZ Quantum Cyber N.V. | Award | 137,141 | - | $0 | Direct |
| Jan 20, 2026 |  INDP Indaptus Therapeutics, Inc. | Award | 25,000 | - | $0 | Direct |
| Dec 23, 2025 | INDP Indaptus Therapeutics, Inc. | Award Option to Buy Common Stock | 25,000 | - | - | Direct |
| Oct 1, 2025 |  TTNP TITAN PHARMACEUTICALS INC | Disposition | 3,313 | - | - | Direct |
| Feb 26, 2025 |  CYCC Cyclacel Pharmaceuticals, Inc. | Award Non-Qualified Stock Option (Right to Buy) | 700,000 | - | - | Direct |
| Sep 26, 2024 |  MINM MINIM, INC. | Award | 159,364 | - | $0 | Indirect |
1-8 of 8 transactions